VANCOUVER, BC

不列颠哥伦比亚省温哥华

,

，

Oct. 21, 2026

2026年10月21日

/PRNewswire/ -- Mapmygenome announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in personal genomics. The strategic transaction expands Mapmygenome's North American footprint and establishes a market-leading platform in DNA testing, gut microbiome health, longevity, and AI-driven multi-omics testing..

/美通社/ -- Mapmygenome 宣布完成对总部位于温哥华的个人基因组学先驱企业 dnaPower Inc. 的收购。这项战略性交易扩大了 Mapmygenome 在北美的业务布局，并建立了一个在 DNA 检测、肠道微生物组健康、长寿以及人工智能驱动的多组学检测领域处于市场领先水平的平台。

Continue Reading

继续阅读

Mapmygenome acquires dnaPower to expand North American operations in precision health and genomics.

Mapmygenome收购dnaPower，以拓展其在北美精准健康与基因组学领域的业务。

By uniting dnaPower with Mapmygenome's global scale and premier CAP-accredited clinical laboratory capabilities, including Vancouver-based Microbiome Insights, acquired in 2025, the acquisition creates a centralized platform for DNA, microbiome, pharmacogenetic, and longevity testing dedicated to proactive, preventive healthcare across Canada and the US..

通过将dnaPower与Mapmygenome的全球规模及顶级CAP认证临床实验室能力（包括2025年收购的位于温哥华的Microbiome Insights）相结合，此次收购打造了一个集中的DNA、微生物组、药物基因组学和长寿检测平台，致力于在加拿大和美国推动主动式、预防性医疗保健。

'Acquiring dnaPower is a pivotal step in scaling our North American operations,' said

“收购dnaPower是我们扩大北美业务的关键一步，”

Anu Acharya, Founder and CEO of Mapmygenome.

Mapmygenome 创始人兼首席执行官 Anu Acharya。

'Pairing dnaPower's commercial trajectory with our CAP-accredited clinical laboratories and AI capabilities positions us to define the next frontier in microbiome, longevity, and precision health testing.'

将dnaPower的商业发展轨迹与我们获得CAP认证的临床实验室及人工智能能力相结合，使我们能够定义微生物组、长寿和精准健康检测领域的下一个前沿。

'Joining Mapmygenome unlocks an extraordinary growth chapter for dnaPower,' said Dr. Lois Nahirney, Founder and CEO of dnaPower. 'Backing from a global leader with elite laboratory infrastructure gives us the foundation to scale rapidly across North America, delivering advanced, high-quality products directly to our clients.'.

“加入Mapmygenome为dnaPower开启了一个非凡的增长篇章，”dnaPower创始人兼首席执行官Lois Nahirney博士表示。“获得拥有顶级实验室基础设施的全球领先企业的支持，为我们奠定了在北美快速扩张的基础，从而直接向客户交付先进、高质量的产品。”

Strategic Highlights

战略亮点

Market Expansion:

市场扩张：

Integrates dnaPower's consumer reach with Mapmygenome's global footprint, technology stack, and R&D pipeline.

将 dnaPower 的消费者触达能力与 Mapmygenome 的全球布局、技术栈及研发管线相整合。

Integrated Longevity Engine:

集成长寿引擎：

Combines multi-omics analytics and clinical laboratory capabilities to deploy new commercial offerings in healthy aging, gut profiling, and epigenetic assessment.

结合多组学分析与临床实验室能力，推出健康衰老、肠道特征分析和表观遗传评估方面的新商业产品。

Centralized Operations:

集中化运营：

Establishes a Vancouver processing hub operating under CAP-accredited and ISO-certified protocols.

建立温哥华处理中心，按照CAP认证和ISO认证的协议运营。

Comprehensive Testing Suite

综合测试套件

Longevity and Gut Health:

长寿与肠道健康：

Advanced shotgun metagenomic sequencing, gut microbiome profiling, epigenetic biological age panels, and longevity insights.

先进的鸟枪法宏基因组测序、肠道微生物组分析、表观遗传学生物年龄检测面板以及长寿洞察。

Genomic and Preventive Health:

基因组学与预防健康：

Whole-genome and exome sequencing, pharmacogenetics, DNA wellness panels, methylation testing, and clinical bioinformatics.

全基因组测序和外显子组测序、药物基因组学、DNA健康检测面板、甲基化检测以及临床生物信息学。

About Mapmygenome

关于 Mapmygenome

Mapmygenome is a global leader in personal genomics, longevity solutions, and precision medicine. Combining AI-driven multi-omics with premier CAP-accredited clinical laboratory infrastructure, Mapmygenome empowers individuals and healthcare providers with actionable insights across whole-genome sequencing, gut health, and healthy aging to transform preventive care worldwide..

Mapmygenome 是个人基因组学、长寿解决方案和精准医疗领域的全球领导者。通过将人工智能驱动的多组学技术与顶尖的 CAP 认证临床实验室基础设施相结合，Mapmygenome 为个人和医疗保健提供者提供涵盖全基因组测序、肠道健康和健康老龄化的可操作洞察，从而推动全球预防性医疗的变革。

Learn more:

了解更多：

mapmygenome.ai

mapmygenome.ai

About dnaPower

关于 dnaPower

Founded in 2008 and based in Vancouver, dnaPower specializes in actionable DNA-based health, nutrition, fitness, methylation, and longevity insights for consumers and practitioners.

dnaPower 成立于2008年，总部位于温哥华，专注于为消费者和从业者提供基于DNA的、可付诸实践的健康、营养、健身、甲基化和长寿洞察。

Learn more:

了解更多：

dnaPower.com

dnaPower.com

About Microbiome Insights

关于微生物组洞察

Microbiome Insights, a Mapmygenome company, is a Canadian provider of CAP-accredited DNA, microbiome, and multi-omics sequencing, analytics, and bioinformatics services.

Microbiome Insights 是 Mapmygenome 旗下公司，作为一家加拿大服务提供商，提供获美国病理学家学会（CAP）认证的 DNA、微生物组及多组学测序、分析和生物信息学服务。

Learn more:

了解更多：

Microbiomeinsights.com

Microbiomeinsights.com

Media Contact

媒体联系人

Email:

电子邮件：

[email protected]

[email protected]

SOURCE Mapmygenome

来源 Mapmygenome

21

二十一

%

%

more press release views with

更多新闻稿浏览量，借助

Request a Demo

申请演示